Providence Health Talk with Dr. Mark Moyad scheduled for Nov. 8

October 12, 2022 Providence News Team

26th annual presentation to the community with Mark Moyad, M.D., MPH

1:30-3:30 p.m. on Tuesday, Nov. 8 
Virtual event on MS Teams Live


Get the latest information on healthy living and dietary supplements at our free community presentation by Mark Moyad, M.D., with a special emphasis on heart health and cancer prevention. Dr. Moyad will share the most current research on which supplements have and have not been helpful in treating common health conditions.

This free Health Talk is presented by the Providence Cancer Center and is open to the public.

Presenter: MARK A. MOYAD, M.D., MPH, University of Michigan Medical Center Jenkins/Pokempner Director of Complementary & Alternative Medicine

About Dr. Mark Moyad 

Mark Moyad, MD, MPH, is a physician public health educator, healthy lifestyle advocate and the primary author of more than 150 medical journal articles and 15 books, including his recent best seller “The Supplement Handbook.” Dr. Moyad is the only physician in the U.S. with an endowed position to study lifestyle changes and dietary supplements, which was originally created and funded by the patients he has helped over the past 25+ years. Learn more

Download the MS Teams app here: Android App / iPhone app 




About the Author

The Providence News Team brings you the updates to keep you informed about what's happening across the organizational ecosystem. From partnerships to new doctor announcements, we are committed to keeping you informed.

More Content by Providence News Team
Previous Article
Trudy, the Facility Dog, Providing Support and Motivation for Patients in Napa
Trudy, the Facility Dog, Providing Support and Motivation for Patients in Napa

Providence Queen of the Valley Medical Center (the Queen) recently became the second hospital in the organi...

Next Article
New clinical studies for invasive breast cancer
New clinical studies for invasive breast cancer

Providence Cancer Institute breast cancer experts are researching new treatments for women with triple-nega...